IS2171B - Samsetning sem eykur hreyfanleika - Google Patents
Samsetning sem eykur hreyfanleikaInfo
- Publication number
- IS2171B IS2171B IS6581A IS6581A IS2171B IS 2171 B IS2171 B IS 2171B IS 6581 A IS6581 A IS 6581A IS 6581 A IS6581 A IS 6581A IS 2171 B IS2171 B IS 2171B
- Authority
- IS
- Iceland
- Prior art keywords
- combination
- increases mobility
- haematopoietic
- mobility
- increases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00830293A EP1147777A1 (en) | 2000-04-18 | 2000-04-18 | Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors |
PCT/EP2001/004105 WO2001078761A2 (en) | 2000-04-18 | 2001-04-10 | Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors |
Publications (2)
Publication Number | Publication Date |
---|---|
IS6581A IS6581A (is) | 2002-10-14 |
IS2171B true IS2171B (is) | 2006-11-15 |
Family
ID=8175292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS6581A IS2171B (is) | 2000-04-18 | 2002-10-14 | Samsetning sem eykur hreyfanleika |
Country Status (31)
Country | Link |
---|---|
US (1) | US20040131588A1 (is) |
EP (3) | EP1147777A1 (is) |
JP (1) | JP5205668B2 (is) |
KR (1) | KR100849491B1 (is) |
CN (1) | CN1183962C (is) |
AT (2) | ATE310532T1 (is) |
AU (2) | AU2001258322B2 (is) |
BG (1) | BG107203A (is) |
CA (1) | CA2406179C (is) |
CY (1) | CY1104971T1 (is) |
CZ (1) | CZ20023426A3 (is) |
DE (2) | DE60140015D1 (is) |
DK (2) | DK1621207T3 (is) |
EE (1) | EE200200596A (is) |
ES (2) | ES2252227T3 (is) |
HR (1) | HRP20020835A2 (is) |
HU (1) | HUP0300560A3 (is) |
IL (1) | IL152328A (is) |
IS (1) | IS2171B (is) |
MX (1) | MXPA02010346A (is) |
NO (1) | NO20024988L (is) |
NZ (1) | NZ522016A (is) |
PL (1) | PL358100A1 (is) |
PT (1) | PT1621207E (is) |
RO (1) | RO121006B1 (is) |
RU (1) | RU2248216C2 (is) |
SI (1) | SI21079B (is) |
SK (1) | SK14892002A3 (is) |
UA (1) | UA73566C2 (is) |
WO (1) | WO2001078761A2 (is) |
ZA (1) | ZA200208413B (is) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8771663B2 (en) | 2000-04-18 | 2014-07-08 | Gentium Spa | Formulation having mobilising activity |
EP1656451A2 (en) | 2003-08-13 | 2006-05-17 | Children's Hospital Medical Center | Chimeric peptides for the regulation of gtpases |
EP1656156A2 (en) | 2003-08-13 | 2006-05-17 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
EP2103689A1 (en) * | 2008-03-19 | 2009-09-23 | Gentium S.p.A. | Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
RU2376985C1 (ru) * | 2008-07-17 | 2009-12-27 | Владислав Николаевич Ласкавый | Средство для активации стволовых клеток |
US8980862B2 (en) | 2010-11-12 | 2015-03-17 | Gentium S.P.A. | Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD) |
CN110079580B (zh) | 2012-06-22 | 2022-12-06 | 真蒂奥姆责任有限公司 | 用于测定去纤维蛋白多核苷酸的生物活性的基于优球蛋白的方法 |
EP3026122A1 (en) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Cellular-based method for determining the potency of defibrotide |
CN106567694A (zh) * | 2016-11-14 | 2017-04-19 | 北京国泰通源技术有限公司 | 智能控水短节 |
WO2019139606A1 (en) * | 2018-01-12 | 2019-07-18 | Cellmig Biolabs Inc. | Methods for generation of cytocapsulae and cytocapsular tubes |
KR20220071274A (ko) | 2019-11-13 | 2022-05-31 | 후지필름 가부시키가이샤 | 가식 필름, 성형물, 및 전자 디바이스 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2154279A1 (de) * | 1970-11-03 | 1972-05-25 | Crinos Industria Farmaco | Medikamente für das fibrinolytische System |
US3899481A (en) | 1970-11-03 | 1975-08-12 | Crinos Industria Farmaco | Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs |
IT1043823B (it) * | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
IT1206341B (it) | 1984-02-16 | 1989-04-14 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio. |
US4694134A (en) | 1985-05-28 | 1987-09-15 | Ajax Magnethermic Corporation | Apparatus for overheating edges of skelp for the production of compression welded pipe |
IT1190313B (it) | 1986-04-17 | 1988-02-16 | Crinos Industria Farmaco | Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante |
US5223609A (en) | 1986-04-17 | 1993-06-29 | Crinos Industria Farmacobiologica S.P.A. | Process for obtaining chemically defined and reproducible polydeoxyribonucleotides |
IT1223322B (it) * | 1987-10-23 | 1990-09-19 | Crinos Industria Farmaco | Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso |
JP2907447B2 (ja) * | 1988-08-24 | 1999-06-21 | 中外製薬株式会社 | 抗血栓剤 |
IT1231509B (it) * | 1989-09-07 | 1991-12-07 | Crinos Industria Farmaco | Composizione farmceutica ad uso topico per la terapia della fragilita' capillare. |
US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
US5977083A (en) * | 1991-08-21 | 1999-11-02 | Burcoglu; Arsinur | Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states |
JP3021906B2 (ja) * | 1992-01-28 | 2000-03-15 | 松下電器産業株式会社 | 電動調理機 |
JPH08127539A (ja) * | 1994-10-31 | 1996-05-21 | Ajinomoto Co Inc | ヒトil−11を含有する末梢血幹細胞増加剤 |
US5856444A (en) * | 1994-11-30 | 1999-01-05 | Chugai Seiyaku Kabushiki Kaisha | Thrombocytopoiesis stimulating factor |
ATE299030T1 (de) * | 1996-07-10 | 2005-07-15 | Meiji Dairies Corp | Verwendung von proteinen aus der mk familie als hämatopoietischer faktor |
WO1999026639A1 (en) * | 1997-11-26 | 1999-06-03 | Allegheny University Of The Health Sciences | Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood |
US6573372B2 (en) * | 1999-01-07 | 2003-06-03 | Heska Corporation | Feline immunoglobulin E molecules and compositions there of |
-
2000
- 2000-04-18 EP EP00830293A patent/EP1147777A1/en not_active Withdrawn
-
2001
- 2001-04-10 SI SI200120022A patent/SI21079B/sl not_active IP Right Cessation
- 2001-04-10 AT AT01931582T patent/ATE310532T1/de active
- 2001-04-10 AT AT05108424T patent/ATE443524T1/de active
- 2001-04-10 JP JP2001576061A patent/JP5205668B2/ja not_active Expired - Fee Related
- 2001-04-10 EE EEP200200596A patent/EE200200596A/xx unknown
- 2001-04-10 KR KR1020027013967A patent/KR100849491B1/ko not_active IP Right Cessation
- 2001-04-10 EP EP05108424A patent/EP1621207B1/en not_active Expired - Lifetime
- 2001-04-10 NZ NZ522016A patent/NZ522016A/en unknown
- 2001-04-10 DK DK05108424.2T patent/DK1621207T3/da active
- 2001-04-10 HU HU0300560A patent/HUP0300560A3/hu unknown
- 2001-04-10 CA CA2406179A patent/CA2406179C/en not_active Expired - Fee Related
- 2001-04-10 WO PCT/EP2001/004105 patent/WO2001078761A2/en active IP Right Grant
- 2001-04-10 EP EP01931582A patent/EP1276497B1/en not_active Expired - Lifetime
- 2001-04-10 CN CNB018082025A patent/CN1183962C/zh not_active Expired - Fee Related
- 2001-04-10 CZ CZ20023426A patent/CZ20023426A3/cs unknown
- 2001-04-10 DE DE60140015T patent/DE60140015D1/de not_active Expired - Lifetime
- 2001-04-10 RU RU2002130719/15A patent/RU2248216C2/ru not_active IP Right Cessation
- 2001-04-10 PL PL01358100A patent/PL358100A1/xx not_active Application Discontinuation
- 2001-04-10 ES ES01931582T patent/ES2252227T3/es not_active Expired - Lifetime
- 2001-04-10 DK DK01931582T patent/DK1276497T3/da active
- 2001-04-10 ES ES05108424T patent/ES2335776T3/es not_active Expired - Lifetime
- 2001-04-10 DE DE60115222T patent/DE60115222T2/de not_active Expired - Lifetime
- 2001-04-10 AU AU2001258322A patent/AU2001258322B2/en not_active Ceased
- 2001-04-10 SK SK1489-2002A patent/SK14892002A3/sk unknown
- 2001-04-10 AU AU5832201A patent/AU5832201A/xx active Pending
- 2001-04-10 PT PT05108424T patent/PT1621207E/pt unknown
- 2001-04-10 IL IL152328A patent/IL152328A/en active IP Right Grant
- 2001-04-10 MX MXPA02010346A patent/MXPA02010346A/es active IP Right Grant
- 2001-04-10 RO ROA200201305A patent/RO121006B1/ro unknown
- 2001-04-10 US US10/432,741 patent/US20040131588A1/en not_active Abandoned
- 2001-10-04 UA UA2002119177A patent/UA73566C2/uk unknown
-
2002
- 2002-10-14 IS IS6581A patent/IS2171B/is unknown
- 2002-10-16 NO NO20024988A patent/NO20024988L/no not_active Application Discontinuation
- 2002-10-17 ZA ZA200208413A patent/ZA200208413B/en unknown
- 2002-10-17 BG BG107203A patent/BG107203A/bg unknown
- 2002-10-18 HR HR20020835A patent/HRP20020835A2/xx not_active Application Discontinuation
-
2006
- 2006-02-08 CY CY20061100179T patent/CY1104971T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL138979A0 (en) | Use of cannabinoids as anti-inflammatory agents | |
TW200505900A (en) | Muscarinic agonists | |
CY1107649T1 (el) | Συνδυασμος ο οποιος περιεχει ενα αντιφολικο αλας και παραγοντα ελαττωσης μεθυλομηλονικου οξεος | |
DE69905368D1 (en) | Oxydiertes thymosin beta 4 | |
IS6581A (is) | Samsetning sem eykur hreyfanleika | |
MXPA03000188A (es) | Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales. | |
MXPA02002681A (es) | Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer. | |
BG106057A (en) | Method of enhancing the efficacy of anti-tumour agents | |
HK1055079A1 (en) | Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders | |
HK1029932A1 (en) | Use of mirtazapine for the manufacture of a medicament for treating sleep apneas. | |
AU2002332488A8 (en) | R-bambuterol, its preparation and therapeutic uses | |
MY122838A (en) | Treating allergic and inflammatory conditions | |
MD990258A (en) | Method of treatment of the acute viral hepatitis B | |
NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
EP1123100A4 (en) | MEMORY IMPROVEMENT BY ADMINISTRATION OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION AND 3-BETA-ESTERS THEREOF | |
YU79802A (sh) | Formulacija sa aktivnošću mobilizacije | |
ATE246479T1 (de) | Absorbierender artikel mit kanal | |
MXPA04000418A (es) | Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas. | |
JPS51139004A (en) | Rail with noise reducing constraction | |
Kim et al. | Synergistic Cooperation Between Human Chorionic Gonadotropin and rIFN-Υ for Induction of Nitric Oxide Synthesis | |
DE69513632T2 (de) | Mikrogranulate enthaltend 5-nitroimidazolderivate | |
UA1032U (uk) | Ректопростатоскоп |